This review is focused on the most recent and promising acellular vaccine proposals. Prevention of spread between animals and monitoring of brucellosis-free flocks/herds and zones; Elimination of ...

The U.S. Food and Drug Administration has approved Symvess, the first acellular tissue engineered vessel indicated for use in adults as a vascular conduit for extremity arterial injury when urgent ...

Acellular therapy projects in the Mayo Clinic Van Cleve Cardiac Regenerative Medicine Program include a biologically potentiated matrix to heal and repair damaged tissue, a shelf-stable product to ...